Xi Chen

6.4k total citations
182 papers, 4.8k citations indexed

About

Xi Chen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xi Chen has authored 182 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 77 papers in Oncology and 56 papers in Immunology. Recurrent topics in Xi Chen's work include Cancer Immunotherapy and Biomarkers (37 papers), Immune cells in cancer (29 papers) and PI3K/AKT/mTOR signaling in cancer (14 papers). Xi Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (37 papers), Immune cells in cancer (29 papers) and PI3K/AKT/mTOR signaling in cancer (14 papers). Xi Chen collaborates with scholars based in China, United States and Germany. Xi Chen's co-authors include Ling Ding, Qiaojun He, Wen Zhang, Chunming Liu, Paul M. Evans, Xi He, Bo Yang, Guangwei Liu, Hongjie Guo and Yuxin Yin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xi Chen

172 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Chen China 39 2.6k 1.5k 1.2k 789 481 182 4.8k
Anping Li China 35 2.7k 1.0× 1.9k 1.3× 1.2k 0.9× 1.2k 1.5× 668 1.4× 54 4.9k
Daniel J. Lindner United States 41 3.2k 1.2× 1.5k 1.0× 1.3k 1.1× 1.1k 1.4× 430 0.9× 133 5.4k
Yi Xiao China 23 2.1k 0.8× 1.7k 1.1× 1.2k 0.9× 966 1.2× 631 1.3× 76 4.2k
Kian‐Huat Lim United States 29 2.4k 0.9× 1.6k 1.1× 781 0.6× 752 1.0× 351 0.7× 97 4.2k
Ping Wang China 37 2.2k 0.8× 806 0.5× 1.2k 1.0× 1.0k 1.3× 332 0.7× 206 4.5k
Junnian Zheng China 38 3.6k 1.4× 1.9k 1.3× 1.2k 1.0× 1.7k 2.2× 629 1.3× 201 5.8k
Vincent Castronovo Belgium 49 4.2k 1.6× 1.6k 1.0× 1.6k 1.3× 995 1.3× 489 1.0× 117 6.7k
Dooil Jeoung South Korea 42 3.0k 1.2× 693 0.5× 1.1k 0.9× 967 1.2× 304 0.6× 166 4.8k
Chuan‐Yuan Li United States 40 3.6k 1.4× 1.6k 1.1× 1.3k 1.0× 1.4k 1.8× 541 1.1× 115 6.0k
Surinder K. Batra United States 41 2.6k 1.0× 1.7k 1.1× 822 0.7× 675 0.9× 596 1.2× 82 4.4k

Countries citing papers authored by Xi Chen

Since Specialization
Citations

This map shows the geographic impact of Xi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Chen more than expected).

Fields of papers citing papers by Xi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Chen. The network helps show where Xi Chen may publish in the future.

Co-authorship network of co-authors of Xi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Chen. A scholar is included among the top collaborators of Xi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Chen. Xi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xi, Fei Song, Peng Xiao, et al.. (2025). Spermine accumulation via spermine synthase promotes tumor cell proliferation in head and neck squamous cell carcinoma. BMC Cancer. 25(1). 402–402. 1 indexed citations
2.
Zhang, Wenhui, Simin Zhu, Xiao Zhang, et al.. (2024). Mitochondrial transplantation reconstructs the oxidative microenvironment within fibroblasts to reverse photoaging. Biochemical and Biophysical Research Communications. 745. 151214–151214. 2 indexed citations
3.
Chang, Hong, Mingxia Li, Linlin Zhang, et al.. (2024). Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity. Cellular Oncology. 48(1). 183–203. 3 indexed citations
4.
Chen, Xi, Yaming Li, Yiran Liang, et al.. (2024). COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk. Oncogene. 43(23). 1742–1756. 10 indexed citations
5.
Wang, Le, et al.. (2023). Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer. Analytical Cellular Pathology. 2023(1). 7365503–7365503. 1 indexed citations
6.
Chen, Xi, et al.. (2023). Comparison of different surgical techniques for chronic subdural hematoma: a network meta-analysis. Frontiers in Neurology. 14. 1183428–1183428. 2 indexed citations
8.
Turner, David C., et al.. (2023). Pharmacokinetics of biologics in gastric cancer. Clinical and Translational Science. 16(4). 564–574. 4 indexed citations
9.
Zhu, Jianfeng, et al.. (2022). Efficacy of maintenance treatment in patients with multiple myeloma: a systematic review and network meta-analysis. Hematology. 27(1). 1069–1088. 3 indexed citations
10.
Lu, Can, Xi Chen, Yuanliang Yan, et al.. (2022). Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma. Frontiers in Pharmacology. 13. 768743–768743. 8 indexed citations
11.
Ding, Ling, Xi Chen, Xiaqing Xu, et al.. (2018). PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3. Cancer Immunology Research. 7(1). 136–149. 98 indexed citations
12.
Liang, Hui, Xi Chen, Qi Yin, et al.. (2017). PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription. Nature Communications. 8(1). 14771–14771. 95 indexed citations
13.
Tripathi, Manish K., Natasha G. Deane, Jing Zhu, et al.. (2014). Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer. Cancer Research. 74(23). 6947–6957. 98 indexed citations
14.
Chen, Xi, Elena Díaz‐Rodríguez, Enrique M. Ocio, et al.. (2014). Genetic and Pharmacologic Evidence That mTOR Targeting Outweighs mTORC1 Inhibition as an Antimyeloma Strategy. Molecular Cancer Therapeutics. 13(2). 504–516. 8 indexed citations
15.
Grieb, Brian C., Maria P. Arrate, Xi Chen, et al.. (2014). Oncogenic Protein MTBP Interacts with MYC to Promote Tumorigenesis. Cancer Research. 74(13). 3591–3602. 34 indexed citations
16.
Liu, Guangwei, Yujing Bi, Bo Shen, et al.. (2013). SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1 α –Dependent Glycolysis. Cancer Research. 74(3). 727–737. 167 indexed citations
17.
Montero, Juan Carlos, Xi Chen, Alberto Ocaña, & Atanasio Pandiella. (2012). Predominance of mTORC1 over mTORC2 in the Regulation of Proliferation of Ovarian Cancer Cells: Therapeutic Implications. Molecular Cancer Therapeutics. 11(6). 1342–1352. 46 indexed citations
18.
Zhang, Bicheng, Jun Wang, Juan Gao, et al.. (2009). Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. Journal of Cellular Biochemistry. 107(1). 134–143. 45 indexed citations
19.
Chen, Xi, Shijun Zhong, Xiao Zhu, et al.. (2008). Rational Design of Human DNA Ligase Inhibitors that Target Cellular DNA Replication and Repair. Cancer Research. 68(9). 3169–3177. 131 indexed citations
20.
Zhang, Wen, Xi Chen, Yoichi Kato, et al.. (2006). Novel Cross Talk of Krüppel-Like Factor 4 and β-Catenin Regulates Normal Intestinal Homeostasis and Tumor Repression. Molecular and Cellular Biology. 26(6). 2055–2064. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026